Pacira BioSciences Files Proxy Statement
Ticker: PCRX · Form: DEFA14A · Filed: Apr 17, 2025 · CIK: 1396814
| Field | Detail |
|---|---|
| Company | Pacira Biosciences, Inc. (PCRX) |
| Form Type | DEFA14A |
| Filed Date | Apr 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, sec-filing
TL;DR
Pacira BioSciences dropped its proxy statement, get ready to vote!
AI Summary
Pacira BioSciences, Inc. filed a Definitive Proxy Statement (DEFA14A) on April 17, 2025, related to its annual meeting. The filing indicates that the company is soliciting proxies from its shareholders. This is a standard regulatory filing required for public companies to inform shareholders about matters to be voted on at the meeting, such as director elections and executive compensation.
Why It Matters
This filing is crucial for shareholders as it outlines the agenda for the company's annual meeting and provides information necessary for them to make informed voting decisions on corporate governance matters.
Risk Assessment
Risk Level: low — This filing is a routine proxy statement, a standard disclosure for public companies, and does not inherently present new risks.
Key Numbers
- 001-35060 — SEC File Number (Identifies the company's filing with the SEC.)
- 25848468 — Film Number (Internal SEC processing number for the filing.)
Key Players & Entities
- Pacira BioSciences, Inc. (company) — Registrant
- 2000 Sierra Point Parkway, Suite 900, Brisbane, CA 94005 (company) — Business and Mail Address
- 0001104659-25-036098 (dollar_amount) — Accession Number
- 20250417 (dollar_amount) — Filing Date
FAQ
What is the purpose of this DEFA14A filing?
The purpose of this DEFA14A filing is to serve as a Proxy Statement, soliciting proxies from shareholders for Pacira BioSciences, Inc.'s annual meeting.
When was this filing submitted to the SEC?
This filing was submitted to the SEC on April 17, 2025.
What is the company's primary business address listed in the filing?
The company's business address is 2000 Sierra Point Parkway, Suite 900, Brisbane, CA 94005.
What is the SEC file number for Pacira BioSciences, Inc.?
The SEC file number for Pacira BioSciences, Inc. is 001-35060.
Does this filing require a fee payment?
According to the filing, no fee is required, as indicated by 'No fee required.'
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 17, 2025 regarding Pacira BioSciences, Inc. (PCRX).